Although these analyses were strictly performed in primary murine Pten-null astrocytes, our RNA expression analysis in human GBM patient-derived primary tumors and outgrowing BTICs clearly demonstrates that the expression of RAD51 and its paralogs remain unchanged regardless of PTEN status. This evidence concerns the gene RAD51 and glioblastoma.